BUY Aurobindo Pharma — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred Intraday)21 Jul 2026, 5:30 am ISTvia Economic Times Stock Recos Overview
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·8 Jul · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Aurobindo Pharma
- SELL — Sahaj Agrawal, Kotak Securities21 Oct 2026 · ~2 weeks · target ₹1,540 · Active
- BUY — Arun Kumar Mantri12 Oct 2026 · ~2 weeks · target ₹1,745 · SL hit
- BUY — Ajit Mishra, Religare12 Oct 2026 · ~2 weeks · target ₹1,820 · SL hit
- BUY — Manas Jaiswal12 Oct 2026 · ~2 weeks · target ₹1,750 · SL hit
- BUY — Rupak De, LKP Securities9 Oct 2026 · ~2 weeks · target ₹1,800 · SL hit
More from ICICI Securities
- BUY CIE Automotive India23 Oct 2026 · ~1 year · target ₹475 · Active
- BUY SAGILITY23 Oct 2026 · ~1 year · target ₹55 · Active
- BUY CREDITACCESS GRAMEEN23 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY Havells India23 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY Balkrishna Industries22 Oct 2026 · ~1 year · target ₹2,675 · Active

